7/24/2019 Anaesthesiology and Intensive Care
1/51
Abhishek Narayan, 2007
1/51
1. General guidelines and of anaesthesiology and intensive care
Peri-operative Careo Assessment
Anamnesis, lab test, risks of anesthesia, types, how to prepare pt
o Prep of the Patiento Intra-operative care
Painless, amnesia, hypnosis, relaxationo Postoperative care
PACU
Mointor vitals, support if needed, pain therapy, treat any complications,ICU or normal ward
Intensive ( Critical) Care Medicineo Management of pt with life threatening patho-physiological conditions
Vital functions
Resp, Cardio Vascu, Metabolic, Neuro
o Main Characteristics Life threatening conditions can be
Broad spectrum of illnesses, of extreme severity, cause complications Multidisplinary Special facilities and staff
o Goals of ICU Maintaining meaningful life Relief of suffering Avoiding harm to the patient Restoration of health. The ultimate goal of treatment in the ICU is a total recovery enabling the patient
to fully participate in society.
As Intensive Care physicians we need to realize that this goal cannot be achievedin all patients.
o Guidelines for ICU Admission and Discharge Criteria
should receive appropriate advanced life-support.
If treatment is unlikely to be associated with a favorable outcome, it isappropriate to limit treatment.
Priority 1 patients
critically ill, unstable patients in need of intensive treatments such asventilator support, continuous vasoactive drug infusions, etc.
Discharge Criteria:o No more need for intensive treatment
o treatment has failed and short term prognosis is poor with littlelikelihood of recovery or benefit from continued intensive
treatment.
Priority 2 patients
patients require the advanced monitoring services of an intensive care unit.
These patients are at risk for the need of immediate intensive treatment,and therefore benefit form intensive monitoring using methods such as
central venous or pulmonary arterial catheters.
Discharge Criteria:
7/24/2019 Anaesthesiology and Intensive Care
2/51
Abhishek Narayan, 2007
2/51
o the likelihood of suddenly requiring intensive treatment hasdiminished.
Priority 3 patients
These are critically ill, unstable patients whose previous state of health, -underlying disease, or acute illness, either alone or in combination, -
severely reduces their likelihood of recovery and / or benefit from ICU
treatment.
Discharge Criteria:o the need for intensive treatment is no longer present,o But they may be discharged earlier if there is little likelihood of
recovery or benefit from continued intensive treatment.
Exclusions
Confirmed brain death (if donor management is not necessary)
Patients who refuse aggressive life-supporting therapy and are forcomfort care only.
Permanent vegetative state
Physiologically stable patients who are at statistically low risk forrequiring ICU treatment
7/24/2019 Anaesthesiology and Intensive Care
3/51
7/24/2019 Anaesthesiology and Intensive Care
4/51
Abhishek Narayan, 2007
4/51
3. Securing Airways
Main purposes of airway managemento Avoidance of airway obstructiono Removal of foreign bodieso Desuction: aspiration, mucus, edemao Tongue
Oxygen therapy Mechanical ventilation
Without Equipment:o Airway Cleaningo Head tild chin lifto Jaw thrust manoeuvreo Recovery Position
Non invasive:o bag and masko Mayo tube (oropharyngeal)o LMAo Intratracheal: oro-, nasotracheal Combitube
Invasive :o non surgical
direct laryngoscopy
bronchoscopy
retrogradeo surgical
cricothyroidotomy
tracheostomy
Complications of Endotracheal Intubationo During intubation :
incorrect tube placement, laryngeal trauma cardiovasculare response, hypoxaemia
o Tube is in place: blockageo Following extubation:
aspiration, airway obstruction, tracheal stenosiso Prolonged Intubation:
Damage to vocal cordGrading a difficult airway
Opening the mouth:1. Visible soft palate, uvula, fauces and pillars
2. Visible soft palate, uvula and fauces
3. Visible soft palate and base of uvula
4. Soft palate is not visible
Laryngoscopy:1. Complete glottis is visible2. Anterior glottis is not visible3. Epiglottis but not glottis is visible4. Epiglottis is not visible
7/24/2019 Anaesthesiology and Intensive Care
5/51
Abhishek Narayan, 2007
5/51
4. Respiratory Insufficiencies: definition, causes, types, and basic guideline of treatment
Factors influencing Respirationo Appropriate content of the inspired airo Respiratory system
airways
Alvoelo-capillary gas exchange Mechanical factors (respiratory muscles, chest wall rigidity)o Circulation/blood
Function of the circulation itself
Buffer-systems of the bloodo Cellular metabolism
Alveolio 300 million in an adulto The surface is appr.70-80 sq.metero Close connection with a capillaryo Gas exchange: alveolar epithel basal membrane capillary endothelo Surfactant, produced by the pheumocytes inreseaes surface tension
Breathing:o Breathing frequency: 14-18/min.o Tidal volume: 500 mlo Minute volume: 14-18 x 500 ml= 7-9 liter
Respiration volume: volume of 1 breath =500ml
Inspiratory reserve: the additional volume whichmay be inspired after normal inspiration,
followed by forced inspiration =2500 ml
Expiratory reserve: normal expiration followed
by forced expiration =1000 ml Vital capacity: the volume which may beexhaled after forced inspiration followed by a
forced expiration = 2500 + 500 + 1000= 4000
ml
Residual volume: may not be exhaled even after forced, voluntary expiration =1500 ml Functional residual capacity: expiratory reserve + residual volume: 1000+1500= 2500 ml. FEV1: forced inspiration- forced expiration. The amount of volume which may be exhaled
within 1 second= approx. 80%
Respiratory insufficiency
An acute or chronic condition in which pulmonary function is markedly impaired, usually
characterized by elevated carbon dioxide or decreased oxygen (or both) in the arterial blood.Patients in respiratory failure often require ventilators to breathe.
Type 1: Failure of oxygenation: hypoxemia Due to ventilation/perfusion mismatch Cause: Pneumonia, PE, pulmonary edema, asthma, emphysema, ARDS, fibrosing
alveolitis
PaO2< 70(60) Hgmm Causes: hypoventilation, shunt, VA/Q disturbance, low FiO2, diffusion disturbances. Symptoms of hypoxia: dyspnoea, restlessness, agitation, confusion, central cyanosis
7/24/2019 Anaesthesiology and Intensive Care
6/51
Abhishek Narayan, 2007
6/51
Type 2: Failure of ventilation: hpyercapnia Due to alveolar hypoventilation with/without ventilation/perfusion mismatch Causes increased pCO2 and or decreased pO2 Severe hypoxaemia may be treated by increasing FiO2 Severe hypocapnia may me an earlier sign than hypoxemia Causes: breathing center problem, spinal cord injury, peripheral nerve injury,
neuromuscular junction (M Gravis), respiratory muscles paralysis, chest wall defect,
Restrictive lung diseases Static lung volume decreases Affects:
Lung parenchyma, pleura, chest wall Spirometry: FRC, RV, TLC Symptoms: Dyspnea, coughing, right cardiac failure, cyanosis, fast superficial
breathing
Forms:
Extrinsic: PTX, pleural effusion
Chest wall deformity Respiratory muscle fatigue Nerve and neuromuscular diseases Obesity
Intrinsic Pulmonary edema, pulmonary embolism
Investigations:
Blood test: FBC, U&E, CRP, ABG, CXR, Micro, Spirometry Management
Type 1: Treat underlying cause, O2 (35-60%) by face mask Assisted ventilation of O2 still low even at 60%
Type 2: Underlying cause, O2therapy Respiratory stimulant (doxapram 1.5-4mg/min IV) may be given if no
improvement with O2therapy
7/24/2019 Anaesthesiology and Intensive Care
7/51
Abhishek Narayan, 2007
7/51
5. Monitoring Ventilation
Signs and Symptoms:
Inspection:o Respiration pattern
Hyperventilation: deep and frequent (e.g. Kussmaul)
Apnea Cheyne-Stokes breathing: both frequency and amplitude increases until a certainpoint, than apnea and starts the next periodical phase (lower brainstem damage)
Atactic: irregular frequency and amplitude (upper brainstem damage)o Frequency
Tachypnea or bradypnea
Tachypnea is always a compensation:
Oxygen demand increased
Oxygen transport is disturbed: e.g.o Circulatory, Anemia
Alveolo-capillary gas exchange is disturbed:o O2 uptake and/or removal of CO2
o dyspnea,o clinical signs of hypoxemia
Incoordinated movements , consciousness disturbance, agitation, tachycardia,slight hypertension, peripheral vasoconstriction, cyanosis ( Red. Hgb >
50g/L)
Bradycardia, bradyaritmia, hypotension severe hypoxemiao accidental respiratory muscle use
COPD-patients: sitting position, fixing the upper part of the body on theirextended arm (use of scalenus muscles, elevating the 1st rib)
Active, forced exspiration: the use of abdominal muscles and inner intercostals(expiration normally is a passive process)
Others: pars alaris of nasal muscleo paradoxical breathing, cyanosis
Ausculation
Diagnostic:
Chest X-Ray-helical CT, Pulsoxymetry
Capnographyo Look at pictures at the bottom of the topico Normal ETCO2 Vaules:
30-43 mmHG, 4.0-5.7 kPa, 4.0-5.6%
Blood gas analysis
Spirometry Ventilated patients:
o Volumes, pressures, fFlows, curve and loop analysis of pressure-volume curve
Goal of Ventilation:o SaO2 above 90%o SaO2 90% corresponds to 60 mmHg paO2o Below SaO2 of 90%: measures are needed to improve oxigenationo Clarify to cause, treat the cause, administer respirator or O2
7/24/2019 Anaesthesiology and Intensive Care
8/51
Abhishek Narayan, 2007
8/51
7/24/2019 Anaesthesiology and Intensive Care
9/51
Abhishek Narayan, 2007
9/51
6. Oxygen therapy and artificial ventilation
Reasons of hypoxemia in postoperative period
Low concentration of O2in inspired airo Normal FiO2 = 0.21, insufficient when under that
Alveolar hypoventilation
o Normal: 4.2L/min Diffusion disturbance
o Type 1 respiratory insufficiency
Ventilation/perfusion ratio disturbanceo Normal V*/Q* = 0.8
Pulmonary shunt (Q*s / Q*T)o The % amount of the circulatory minute volume passing the pulmonary capillary network
without getting in contact with alveoli
o 3-8 % - Normalo 5-20 % - Usually tolerableo 20-30 % - May be life threatening if cardiac function is deceased
o >30 % - Life threatening, severe hypoxemia
FiO2o PaO2is 5 x higher than FiO2
o FiO2 =0.21o The FiO2- PaO2 ratio reflects the alveolo-capillary gas exchangeo Shows pulmonary dysfunction even in case PaO2 is normalo PaO2 may be normal or elevated during oxygen therapy
Normal: 4.0 -5.0 Moderate Pulmonary dysfunction: 2.0 3.9 Sever Pulmonary dysfunction: 35 or
7/24/2019 Anaesthesiology and Intensive Care
10/51
Abhishek Narayan, 2007
10/51
Basic Forms of Respiratory Care:
Patient efforto None: controlled modeo Needs support: assisted modeo Uncertain or changing: assist-control mode
According to invasivenesso Invasiveo Non-invasive
Administered pressureo Positiveo Negative (iron lung)
Mechanical Ventilation
Controlled:o No patient triggero What is controlled:
Inspiratory time
Pattern of inspiration
o Exspiration is passive
Types of mechanical ventilation
Intermittent positive pressure ventilation (IPPV).o The lungs are intermittently inflated by positive pressure generated by a ventilator, and
gas flow is delivered through an endotracheal or tracheostomy tube.
o Tracheal intubation not only allows institution of IPPV, but also reduces dead space andfacilitates airway suctioning.
However, it is also possible to deliver positive pressure ventilation to cooperative patients in anon-invasive manner through a tight- fitting face or nasal mask (NIPPV).
Two main types of ventilators commonly in use in ICU
those that deliver a preset tidal volume
those that deliver a preset inspiratory pressure during each inspiration.
Modern ventilators allow different modes of ventilation
Types of Ventilation
Volume-cycled ventilation occurs when the ventilator delivers a preset tidal volume regardless of
the pressure generated. The lung compliance (stiffness) of the lungs determines the airway
pressure generated, so this pressure may be high if the lungs are stiff, with the resultant risk of
barotrauma (rupture of the alveoli resulting in pneumothoraces and mediastinal emphysema). Pressure-preset ventilation aka PCV (Pressure Controlled Pressure) is where the ventilator
delivers a preset target pressure to the airway during inspiration. The resulting tidal volume
delivered is therefore determined by the lung compliance and the airway resistance.
7/24/2019 Anaesthesiology and Intensive Care
11/51
Abhishek Narayan, 2007
11/51
Modes of ventilation
Controlled Mechanical Ventilation (CMV).
o Ventilation with CMV is determined entirely by machine settings including the
airway pressure/tidal volume, respiratory rate and I:E ratio. This mode of ventilation
is not often used in ICU as it does not allow any synchronization with the patient's
own breathing.
o As a consequence, CMV is not well tolerated and patients require heavy sedation or
neuromuscular blockade to stop them 'fighting' the ventilator, thereby resulting in
inefficient gas exchange.
o CMV is normally used in theatre when the patient is receiving a full general
anesthetic to optimize surgical conditions.
o Uncomfortable for the patient, triggers only additional mechanical breaths, possible
baro-trauma, choice of inspiratory flow is difficult, difficult to set in active patients,
may increase WOB.
o
Assisted Mechanical Ventilation (AMV).
o designed to work with the patients' own respiratory effort.
o
The patient's inspiratory effort is detected and triggers the ventilator to 'boost' theinspiratory breath.
Possible triggers: time, pressure, flow
o These modes have two important advantages;
better tolerated by the patient and so reduce sedation
allow patients to perform muscular work throughout the breath, thereby
reducing the likelihood of developing respiratory muscular atrophy.
o The ventilator-assisted breaths can be supported either by a preset inspiratory
pressure or by a preset tidal volume. There are several variations of assisted
ventilation.
Intermittent mandatory ventilation (IMV) is a combination of spontaneous and mandatory
ventilation.
o Between the mandatory controlled breaths, the patient can breathe spontaneously andunassisted.
o IMV ensures a minimum minute ventilation, but there will be variations in tidal
volume between the mandatory breaths and the unassisted breaths.
o Problem: no synchronization between patient effort and mechanical breaths (danger
of lung over distension)
Synchronised intermittent mandatory ventilation (SIMV).
o With SIMV, the mandatory breaths are synchronised with the patient's own
inspiratory effort which is more comfortable for the patient.
Pressure-support ventilation (PSV) or Assisted spontaneous breaths (ASB).
o A preset pressure-assisted breath is triggered by the patient's own inspiratory effort.
o This is one of the most comfortable forms of ventilation.
o The preset pressure level determines the level of respiratory support and can bereduced during weaning.
o There are no mandatory breaths delivered, and ventilation relies on the patient
making some respiratory effort.
o There is, however, no back up ventilation should the patient become apnoeic, unless
this mode is combined with SIMV.
o Does not work in paralyzed patients. Minute ventilation is not guaranteed
7/24/2019 Anaesthesiology and Intensive Care
12/51
Abhishek Narayan, 2007
12/51
o Positive End Expiratory Pressure (PEEP) is used with all forms of IPPV.o A positive pressure is maintained during expiration expanding under ventilated lung, and
preventing collapse of the distal airways.
o This results in improved arterial oxygenation.o PEEP causes a rise in intrathoracic pressure and can reduce venous return and so
precipitate hypotension, particularly in hypovolaemic patients.
o With low levels of PEEP (5-10cmH2O), these effects are usually correctable byintravenous volume loading.
Continuous Positive Airway Pressure (CPAP) is effectively the same as PEEP, but in spontaneously
breathing patients.
Ventilation Parameters
o Tidal Volumeo No ALI: 10 ml/kgo ARDS: outcome is better in case of low TV
6 ml/kg 12 ml/kg
o Frequencyo ACV : 4/min (only for backup is needed)o SIMV: 10/min. at the beginning, should be increased when neededo PSV: no frequency preset is necessary
o Sensitivity triggero May be:
Flow, pressure, timeo Usually it is negative pressure: 1- 3 H2Ocmo Appropriate trigger sensitivity is important: low sensitivity too frequent triggering
danger of respiratory alkalosis
o FiO2
o High FiO2 potentially toxic Limit: 0,6
o Goal: the lowest FiO2, resulting in acceptable oxygenationo What is acceptable?
60 mmHg O2, saturation above 90%o
o PEEPo Inspiratory flow
7/24/2019 Anaesthesiology and Intensive Care
13/51
Abhishek Narayan, 2007
13/51
7. Practical demonstration of oxygen therapy and mechanical ventilation.
8. Practical conduct of mechanical ventilation
From: http://www.nda.ox.ac.uk/wfsa/html/u16/u1609_01.htm
NOTE: I am not sure what topics 7 and 8 require. Listed is general info about ventilation and their
uses. Refer to topic 6 as and when needed.
Initiating Mechanical Ventilation
When initiating artificial ventilation the aim is to provide the patient with a physiological tidal
volume and ventilatory rate adapted to meet the patient's underlying condition
Initial ventilator settings:
FiO2 1.0 initially but then reduce
PEEP 5 cm
H2O Tidal volume 7-10 ml/kg
Inspiratory pressure 20 cmH2O (15cmH2O above PEEP)
Frequency 10 - 15 breaths per minute
Pressure support (ASB) 20 cmH2O (15cmH2O above PEEP)
I:E Ratio 1:2
Flow trigger 2 l/min
Pressure trigger -1 to -3 cmH2O
'Sighs' Nil - formerly thought to prevent atelectasis, but
no longer considered effective
These settings should be titrated against the patient's clinical state and level of comfort.
OPTIMIZING OXYGENATION
Initially set FiO2at 1.0 and then wean rapidly to a FiO2adequate to maintain SaO2of >93%.
FiO2of greater than 0.6 for long periods should be avoided if possible because of the risk ofoxygen-induced lung damage.
Strategies to improve oxygenation (other than to increase FiO2) include increasing the meanairway pressure by either raising the PEEP to 10cmH2O or, in pressure-preset ventilation modes,
by increasing the peak inspiratory pressure.
However, care should be taken to avoid very high inflation pressures (above 35cmH2O) as thismay cause barotrauma to the lungs.
More complex strategies to improve oxygenation may be required in severely hypoxic patientseg acute respiratory distress syndrome (ARDS) or acute lung injury from a variety of causes.
o In severe hypoxia, it may be possible to improve oxygenation by increasing the PEEPfurther to 15 cmH2O (or above) and using small (6-8mls/kg) tidal volumes more
frequently.
7/24/2019 Anaesthesiology and Intensive Care
14/51
Abhishek Narayan, 2007
14/51
o However, this may cause a reduction in blood pressure and may be poorly tolerated bythe patient requiring intravenous fluid loading and inotropic or vasopressor therapy.
Another strategy is to prolong the inspiratory time. Normal inspiratory to expiratory ratio is 1:2but oxygenation may be improved if this ratio is changed to 1:1 or even 2:1.
o However, these alterations are often not well tolerated by the patient who may requireheavy sedation.
o Not infrequently, due to a reduced minute volume the PaCO2may rise.o In some patients this technique is used deliberately 'Permissive Hypercapnia'.
In severe ARDS the patient can be repositioned and ventilated in the prone (face down) position.o This may improve oxygenation by re-expanding collapsed alveoli and improving the
distribution of blood perfusion in the lung relative to ventilation.
o In this position, patient monitoring and care is obviously difficult, and this approachshould be undertaken with careful monitoring and care.
Problems during mechanical ventilation
o 'Fighting the ventilator'o When the patient starts to breathe out of phase with the ventilator or becomes restless or
distressed during IPPV, there is a fall in the delivered tidal volume due to a rise inrespiratory resistance.
o This results in inadequate ventilation and hypoxia.o There are a number of causes including:
Patient factors - Breathing against the ventilators inspiratory phase, breath holdingand coughing.
Decreased pulmonary compliance - pulmonary pathology, including oedema orinfection and pneumothorax.
Increased airway resistance - bronchospasm, aspiration, excess secretions Equipment - ventilator disconnection, leak, failure. ET tube blocked, kinked,
dislodged
Weaning
Patients recovering from prolonged critical illness are at risk of developing 'critical illness
polyneuropathy'. In this condition, there is both respiratory and peripheral muscle weakness, with
reduced tendon reflexes and sensory abnormalities. Treatment is supportive. There is evidence that
long-term administration of some aminosteroid muscle relaxants (such as vecuronium) may cause
persisting paralysis. For this reason, vecuronium should not be used for prolonged neuromuscular
blockade.
Indications for weaning
The decision to start weaning is often subjective and based on clinical experience. However, there
are some guidelines that may be helpful:
Underlying illness is treated and improving
Respiratory function:
o Respiratory rate < 35 breaths/minute
o FiO2< 0.5, SaO2> 90%, PEEP 5ml/kg
o Vital capacity > 10 ml/kg
o Minute volume < 10 l/min
Absence of infection or fever
7/24/2019 Anaesthesiology and Intensive Care
15/51
Abhishek Narayan, 2007
15/51
Cardiovascular stability, optimal fluid balance and electrolyte replacement
Modes of Weaning
There is debate over the best method for weaning and no one technique has been found to be
superior to others. There are several different approaches.
Unsupported spontaneous breathing trials. The machine support is withdrawn and a T-Piece
(or CPAP) circuit can be attached intermittently for increasing periods of time, thereby
allowing the patient to gradually take over the work of breathing with shortening rest periods
back on the ventilator.
Intermittent mandatory ventilation (IMV) weaning. The ventilator delivers a preset minimum
minute volume which is gradually decreased as the patient takes over more of the respiratory
workload. The decreasing ventilator breaths are synchronised to the patient's own inspiratory
efforts (SIMV).
Pressure support weaning. In this mode, the patient initiates all breaths and these are 'boosted'
by the ventilator. This weaning method involves gradually reducing the level of pressure
support, thus making the patient responsible for an increasing amount of ventilation. Once
the level of pressure support is low (5-10 cmH2O above PEEP), a trial of T-Piece or CPAPweaning should be commenced.
Failure to wean
During the weaning process, the patient should be observed for early indications of fatigue or failure
to wean. These signs include distress, increasing respiratory rate, falling tidal volume and
haemodynamic compromise, particularly tachycardia and hypertension. At this point it may be
necessary to increase the level of respiratory support as, once exhausted, respiratory muscles may
take many hours to recover.
It is sensible to start the weaning process in the morning to allow close monitoring of the patient
throughout the day. In prolonged weaning, it is common practice to increase ventilatory supportovernight to allow adequate rest for the patient.
7/24/2019 Anaesthesiology and Intensive Care
16/51
Abhishek Narayan, 2007
16/51
9. Intensive treatment of the hemodynamically unstable critically ill
Signs and Symptoms:o Central Nervous System: decreased mental statuso Cardiac: chest pain, ischemia on ECG, and wall motion abnormalities on echocardiogramo Renal: decreased urine output, BUN/creatinine increases,o GI: abdominal pain, decreased bowel sounds,o Periphery: cool limbs, poor capillary refill, weak pulses
Shock:o Shock is a syndrome of hypotension and decreased tissue perfusion. Initially
neurohumoral compensatory mechanisms can maintain perfusion to vital organs. If
appropriate treatment is not promptly instituted, these comp. mech. are overwhelmed,
producing ischemia, cellular damage, multiple organ failure, and death.
Types of shock:
Hypovolaemic (acute loss>20% of blood), Carcinogenic, Obstructive(mech. obstacle to venous return or arterial outflow), distributive
(decreased vascular tone)
o Patho-physiology of shock:
Prolonged hypotension (decreased DO2) Neurohumoral response. Stress hormones: catecholamines, ADH, ACTH,
glucagon (enhanced myocardial contractility, peripheral vasoconstriction)
Metabolic response (hyperglycemia)o Effect of Shock:
CNS - confusion and obtundation Cardiovascular - MI, impaired contractility, dysrhythmias Resp. syst. - Acute resp. failure, bronchospasm, a. pulm. hypertension, V/Q
mismatch, ALI-ARDS
Renal system - GFR decreases, Acute tubular necrosis Gastrointestinal damage to GI mucosa, predispose to translocation of bacteria.
GI hemorrhage, ileus, pancreatitis, hepatic failure.
Haematologic syst. - Platelets and factors may be depleted. DICo Management
Airway, Positive-pressure ventilation Peripheral iv. access. Standard monitoring.(ECG, SpO2, NIBP, urinary output, core temperature) Extra monitoring (IBP, CVP measurement, PAC, PICCO)
Hypovolaemic Shock:o Etiology - hemorrhage, vomiting, gastric suctioningo Patophysiology - Decreased venous return low RRo Clinical presentation - hypotension, weak pulses, flat neck veins, cold and clammy skino Therapy:
Volume replacement: Crystalloids. (Saline, RL), Hypertonic saline 3%, Colloids(hydroxyethyl starch, dextrans)
Human albumin, blood products Vasopressors
7/24/2019 Anaesthesiology and Intensive Care
17/51
Abhishek Narayan, 2007
17/51
Cardiogenic Shock:o Causes: AMI and its complications, dysrhytmias, acute myocarditis, contusion,
pharmacologic depressants, proximal aortic dissection)
o Pathophysiology: Decreased contractility causes decreased SV, CO, RRsysto Clinical manifestation: hypotension with cutaneous vasoconstriction, cold extremities,
cyanosis, Jugular Venous Distension, new murmur, S3 gallop, pulmonary rales.
o Therapy: Inotropic drugs
Dobutamin (1,2, alfa1)o Pos. Inotropic and chronotropic effects.o Central line is preferable.o low dose:2-5 ug/kg/min dopaminerg effect, increases renal and
splancnic blood flow.
o medium dose: 5-10ug/kg/min 1 effect increases contractility, HR,RRsyst
Norepinehrine (alfa1, alfa2, 1)o Dosage: 1-20 ug/mino Increases vascular tone, so can treat hypotension.
o Adverse effects: Intense peripheral vasoconstriction can causeorgan hypoperfusion and ischemia.
Epinehrin (alfa1, alfa2, 1, 2)o Indications: Refractor hypotension. Bronchospasm, anaphylaxis,
cardiac arrest.
o Effects: 1-2 g/min 2 bronchodilatationo 1: HR, contractility increases.o Alfa1: vascular tone increases.o Inhibition of inflammatory mediator release by mast cells, and
basophils.
Phosphodiesterase inhibitors (amrinone, milrinone)
Positive inotrop and vasodilator effect.
Adverse effects: tachycardia, dysrhytmias, thrombocytaemia, abnormalliver function test.
Vasodilatators (nitrates, labetalol, ACE inhibitors) Intravenous sedatives and analgesics. (bezodiazepins, opioids) Thrombolysis, PTCA, cardiac surgery Intraaortic balloon counterpulsation (IABC)
o Bradycardia: HR150/min Drugs: cordarone, lignocaine, propafenon Cardioversion (synchronised, 100, 200, 360J) Defibrillation (, 200, 200, 360J) No pulse.
Neurogenic Shock:o Traumatic spinal injuryo Clinical presentation: hypotension, peripheral neurologic deficit.o Management: Patent airway, ventilation, fluid resuscitation, alfa agonists, stabilizing
surgery.
7/24/2019 Anaesthesiology and Intensive Care
18/51
Abhishek Narayan, 2007
18/51
Anaphylactic Shock:o Antibody mediated reaction that occurs on response to a particular antigen in previously
sensitized individuals.(IgE)
o Clinical manifestations: Skin: flushes, urticaria, pruritus. Resp. System: upper airway obstruction, bronchoconstriction, produces dyspnoe.
o Management: Identification and discontinuation of the suspected antigen. Airway management, volume resuscitation. Epinehrin 0,1-0,5 mg. Corticosteroids maximal effect 4-6 hours later. Dose: hydrocortison 4*200 mg
Obstruction Shock:o Causes: tension PTX, pericardiac tamponade, abdominal compartment sy. , pos. Pressure
ventilation, PEEP, auto PEEP, pulmonary embolism.
o Clinical features: Hypotension, tachycardia, resp. Distress, JVD, increase andequalization of central pressures.
o Management: Volume resuscitation. Inotropic support. Tension PTX :emergency needle aspiration Abdominal compartment: decompressive laparotomy Cardiac tamponade: pericardiocentesis. Pulmonary embolism: thrombolysis.
7/24/2019 Anaesthesiology and Intensive Care
19/51
Abhishek Narayan, 2007
19/51
10. Possibilities of hemodynamic monitoring: CVP, pulmonary artery catheter,
PiCCO, NICO, central venous oxygen saturation etc.
Central Venous Pressureo Possibilities:
Fluid manometry
Electricalo Veins used:
V. Subclavia, V. jugularis interna, V. Femoralis, V.cephalica and basilica
o Spontaneously breathing patient: 5-10 H2O cmo Artificially ventilated patients: 3-5 H2O cm highero CVP = pressure in the right atrium
Determined by right heart function and pressure in the vena cava Thus, it reflects:
Volume status, right heart status
Changes in value are more important then the value it self Normally CVP reflects the left atrial pressure, if and only if no right sided heart
failure and pulmonary vascular resistance is normalo Three spikes (a, c, v)o Two descents (x, y)
a: atrial contraction x: atrial relaxation c: ventricular contraction v: atrial filling y: opening of tricuspidal valve
before ventricular filling
o Possible Complication Carotid puncture, PTX, Air
embolism, arrhythmias,
perforation, cardiac tamponade
Brachial plexus, vagus damage chylothorax
Pulmonary Artery Cathetero Also called the Swan Ganz catheter
Inserted into the Subclavian veinor Internal jugular vein
Swimmed up to the pulmonary artery by the blood flow.o Makes use of Ficks principle of diffusiono 3 West zones of the lung
I. zone: PA>Ppa>Ppv II. zone : Ppa> PA> Ppv III:zone: Ppa> Ppv> PA
o Complications Thrombosis, Pulmonary artery rupture,
Sepsis, Endocarditis, Lung infarction,
Valve damage
o Can measure: CVP, RVEDP, PAP, PCWPo Can calculate: CO, CI, SV, SVR, PVR
7/24/2019 Anaesthesiology and Intensive Care
20/51
Abhishek Narayan, 2007
20/51
Central Venous Oxygen Saturation (ScvO2)o DO2: the amount of oxygen transported by the circulation to the tissues
Determinants:
Oxygen content: Hemoglobin (Hb), Oxygen saturation (SO2)
Cardiac Outputo VO2: Oxygen consumption
Oxygen consumption depends upon the peripheral metabolism and its alterations,such as:
Exercise, fever, hypermetabolismo ScvO2 central venous oxygen saturation
Oxygen saturation in the superior vena cava Normal value is: 70-80 %
Decreased DO2or increased VO2o SvO2 mixed venous oxygen saturation
the saturation of the Hgb in the pulmonary artery, i.e. just after the right heart
PiCCO - Pulse Contour Cardiac Outputo Uses principle of Thermo-dilution
o This system can measure intra- and extrathoracic volumes and monitors both left andright side of the heart function.(CO, preload volume, contractility, resistance, volume
responsiveness, extravascular lung volume)
o Applies thermodilution to measure COo Necessary cannula:
Central venous arterial
o Advantages: Easy use, less invasive, beat-to beat registration of the actual parameters
o Indications: Patients in whom cardiovascular and circulatory volume status monitoring are
necessary.
o Contraindications: Patients in whom there are arterial access restrictions, for example due to femoral
artery grafting or severe burns in areas where the arterial catheter would normally
have been placed.
Note: The Axillary or Brachial artery can be used as an alternative site.Additionally a long radial artery catheter can be placed for short term use.
May give incorrect thermodilution measurements in patients with intracardiacshunts, aortic aneurysm, aortic stenosis, mitral or tricuspid insufficiency,
pneumonectomy, macro lung embolism and extracorporeal circulation (if blood is
either extracted from or infused back into the cardiopulmonary circulation).
NICO Non Invasive Cardiac Output Monitoringo Calculating circulating minute volume based upon the exhaled CO2-concentration (Fick-
principle)
o Measures hemodynamical and respiratory parameters
7/24/2019 Anaesthesiology and Intensive Care
21/51
Abhishek Narayan, 2007
21/51
7/24/2019 Anaesthesiology and Intensive Care
22/51
7/24/2019 Anaesthesiology and Intensive Care
23/51
Abhishek Narayan, 2007
23/51
o Diarrhea, preoperative anterograd rinsing of the bowels, intestinalpolyposis, Intestinal fistulas in Crohns disease
Renal losses:o Diuretics, hypomagnesemia, hyperaldosteronism, glucocorticoid
effect
Therapy
Potassium supplement ( p. Os, i.v.) 2-3 mmol/kg/dayo max. speed of infusion: 20 mmol K+ / hour
Potassium deficiency in mmol =o =( 4,5 mmol/l - Se K+) x ECF(1) x 2 == (4,5 mmol/l - Se K+ ) x 0,4 x BWkgo Hyperkalemia
>5.5 mmol/l ECG: high, peaked T waves, wide QRS, AV block, loss of p wave Causes:
Metabolic acidosis, lack of mineralocortikoids, hypoxia, Olyguria, anuria,hemolysis, over correction of hypokalemia, drug side effects
Therapy:
Treat it over > 6mmol/l with
20-30 ml calcium gluconicum 10% 100 ml 20% glucose + 20 IE Insulin ( 1 IE Insulin / 2 g glucose), in 30
minutes control
40-100 ml 4,2 % Na HCO3 ( 0,5 mmol/ ml)
Low dose epinephrine, furosemid
Calciumo Calcium norm. value: 2,2-2,6 mmol/lo Ionized calcium norm. value : 1,1- 1,4 mmol/lo Regulation:
Parathormon, calcitonin, vitamin D Contraction of muscles, release of neurotransmitters, coagulation, bones
o Hypocalcemia Se Ca < 2,2 mmol/l, ionized Ca < 1,1 mmol/l Cause:
Massive transfusion, use of heart-lung machine, Hypoparathyreosis,Kidney disease. Enteral absorption disturbances, lack of vitamin D, lack
of magnesium
Signs:
Cardiac signs < 0,75 mmol/l , ECG-elonged QT
Paresthesia, laryngospasm, convulsion Therapy
Ca++substitution is indicated in decreased ionized Ca value.
Ca++substitution with the help of Ca-gluconicum, CaCl2.
o 10 ml Ca-Gluconicum 10 % (0,225 mmol/ml)o 10 ml Ca Gluconicum 20 % ( 0,45 mmol/ml)o 10 ml CaCl2 (0,5 mmol/ml)
o Hypercalcemia Cause:
Primary hyperparathyreosis, Vitamin D in toxicity, paraneoplasticsyndrome, sarcoidosis
Sings
ECG: Shorter AP, RF, QT distance. If Se Ca > 9 mmol/l ventricularfibrillation
7/24/2019 Anaesthesiology and Intensive Care
24/51
Abhishek Narayan, 2007
24/51
Therapy:
Glucose 5 %
Diuretics (Furosemid)
Isotonic Na-Sulphuricum ( 1 liter every 3-6 hours, with 20-40 mmol K+).
EDTA in arrhythmic disorders
Hemodialysis
Magnesiumo Hypermagnesemia
Causes:b
Antacids, Iatrogenic Signs:
Sedation, weakness of muscles, hyporeflexion, blood pressure decreases Therapy:
I.v. Ca++, Diureticso Hypomagnesaemia
In critically ill patients Signs:
Weakness, paresthesia, contraction of muscles, atrial fibrillation,
increasing muscle irritability Therapy:
MgSo4
7/24/2019 Anaesthesiology and Intensive Care
25/51
Abhishek Narayan, 2007
25/51
12. Guidelines of volume therapy
Isomosis:
Norm. osmolality: 290 mosmol/kg water= = 2 X Na + BUN + Glucose Hypoosmolarity -> hyponatremia Hyperosmolarity -> Na^, Glu^, BUN^
o
Ringers lactate: 273 mosmol/lo NaHCO3 8,4%: 2000 mosmol/lo 5% glucose : 253 mosmol/lo NaCl 0,9% : 308 mosmol/l
Possible disturbances of water and salt distributiono Isotonic dehydrationo Hypertonic dehydrationo Hypotonic dehydration
Signs of Dehydrationo 5%: Thirst and dry moutho 5-10%: Decreased peripheral perfusion, decrease skin turgor, postural dizziness,
oligurria, decrease CVP, tachycardia
o 10-15%: Increase in respiratory rate, hypotension, anuria, delirium, comao >15%: Life threatening
Crystalloidso Cheap effective, few side effectso Balanced Salt Solutions (BBS)
Hartmanns (Ringers), osmolality is similar to ECF, good for restoring extracellular volume
First line in preoperative period Reduce iatrogenic hyperchlormemic metabolic acidosis
o Normal Saline 0.9% Common for electrolyte replacement Contain high sodium and Cl, can cause hyperchlormemic metabolic acidosis Preferred in hypovolemic resuscitation, good for replacing fluid lose via
electrolyte rich GI loses
o Glucose Solution Aka Dextrose, 5% or 4%-saline 0.18% Glucose 5% - way of giving free water, used to restore dehydration associated
with water loss. Hyponatraemia may occur.
Glucose 10%, 20% and 50% for resorting normal glucose levels
Colloidso Homogenous, non-crystalline substances that have large molecules or ultramicroscopic
particles, which stay in the vascular compartment to expand the functional plasma
volume
o
HAS- Human Albumin Solution MW = 69 000, used as a 4.5% solution for hypovolemia and as a salt poor 25%
for the treatment of hypoalbuminaemia
o Gelatins Succinylated gelatins (MW 30 000), 4% in NaCl solutions Made from bovine collagen from BSE-free herds
o Hydroxyethyl starches (HES) MW 70 000 to 450 000 Made from hydrolysed amylase resistant maize. Vary in MW, molar substitution,
and degree of substitution
7/24/2019 Anaesthesiology and Intensive Care
26/51
Abhishek Narayan, 2007
26/51
o Dextrans Branched polysaccharides from bacterial actions on sucrose 10% dextran 40 (MS 40 000), 6% dextran 70, and supplied in 0.9% saline
solutions
Used as plasma expanders
Therapy of dehydrationo Laboratory data: Htc, acidosis, urine density (>1020), Na 450
mosmol/kg
o Hemodynamics: CVP, Pulm.art.pressureo Administer:
Crystalloids extreme volumes may cause edema Colloids i.vasculary (3-6h) + complications!
o Indication: i.v. deficiency (bleeding, shock) in hypoalbuminemia, fluid resuscitationo Dextran40,70,starch,HES,Voluven,Gelifundol,Salt1o%
Hyperhydration:o Heart insufficiencyo Kidney insufficiencyo
Iatrogenico Iso-, hyper-, hypotonic
7/24/2019 Anaesthesiology and Intensive Care
27/51
Abhishek Narayan, 2007
27/51
13. Indications and practice guidelines of clinical nutrition
Daily energy expenditure
Basic energy requirement: 35-40 kcal/m2/h
Resting metabolic need : 10% moreDetermination of Energy Needs:
Estimated needs: 30 kcal/kgBW/day x CF Calculated needs: Basic needs x CFo Harris-Benedikt equation: basic needs
Male: 66,5(13,8 x weight) + (5,0 x height) (6,8x age) Female: 65,5 (9,6 x weight) + (1,9 x height) (4,7 x age)
o Stein-Levine formula: Male: 1,05 x 24 x height Female: 0,97 x 24 x height
Indirect calorimetry: gold standard
Where CF= correction factor, which changes in fever, surgery, visceral damage, fractures, sepsis,burns
Nutritional Needs:o Energy: 25-40 kcal/kgBWo Protein 20%o Fat 30%o Carbohydrates 50%o Protein 1.2-1.5-2.0 g /kg/dayo carbohydrates 1-5 g/kg/day (max. 5!)o Fat 1-2 g/kg/dayo Water 1 ml / kcalo Minerals, Vitamins
Goals of Clinical Nutrition:
Primary:
o Providing non-protein energy, restoration of wasted structural proteins
Secondary:o support of immune response, prevention of complications
Proper nutrition can help in:o Improvement in wound healing , catabolic reaction decreases, improvement in
gastrointestinal permeability, less complications, shorter hospital stay
Steps of Clinical Nutrition:o Delineation of malnourished patientso Nutrition plan (caloric and composition)o Decision about the proper nutritiono Continuous control
Indications for clinical nutrition:o Inappropriate food intake for more than 5 dayso More than10% loss in body weight within 1 montho Actual body weight < 80% of ideal body weighto BMI
7/24/2019 Anaesthesiology and Intensive Care
28/51
Abhishek Narayan, 2007
28/51
Forms:o Total
Enteral: Oral or tube feeding
Side effects: gastric residuum, aspiration pneumonia Parenteral
Side effects: gut mucosa atrophy, overfeeding, hyperglycemia, infections
2 forms:
o Total parenteral nutrition (TPN)o Partial/ protein-preservating parenteral nutrition ( PT)
o Partial
Parenteral Nutrition:o Indication:
when enteral nutrition is not possible! (e.g. short bowel syndrome, chylothorax) If gastric emptying is disturbed, jejunal feeding should be administered.
o Peripheral TPN: The limit of administration in peripheral veins 800-1200 mosm/l
o Central venous: Above 1200 mOsm/l of osmolarity
o Solutions: Mono-solutions, multiple component solutionso Complications: Volume overload, Infection, metabolic shifts
Metabolic:
Essential amino acids are not provided during TPN (glutamin, cystein)
Too high CH: energy consumption increases, VCO2 and respiratory workincreases, hepatic steatosis, immune disturbances
Enteral Nutrition:o Advantages:
More physiological G. I. functions may be used: peristaltic, digetive, selective absorption Preserves bowel mucosa! (against bacterial translocation)
Glutamine supplementation is possible Early enteral nutrition: prevents intestinal damage
o Speed: 25-30 ml / hour, followed by an increase of 10-25 ml/1-4 hourso Indication: Dysphagia, mechanical causes, diseases of the stomach , appetite disturbance,
special need for food intake
o Contraindication: insufficient bowel function, illues, peritonitis, postaggression syndromeo Can be Oral, Gastric or jejunal
Gastric:
Nasogastric tube: for les than 4 weeks,
Gastrostomy
Percutaneous endoscopic gastrostomy Duodenal and jejunal feeding:
Nasointestinal tube: balloon, mandrine, Peristaltics pushes forward,endoscopic,
Transcutaneous intraabdominal tubeo Surgical method, endoscopic, PEJ (Percutanenous Endoscopic
Jejnostomy)
o Dosage: 1 g protein/kg/day + 150-200 kcal ( fat, CH) Requirements: Motility, resorption
o Contraindications: Absorption disturbance, Technical problems
7/24/2019 Anaesthesiology and Intensive Care
29/51
Abhishek Narayan, 2007
29/51
Refeeding Syndrome:o related to oral anteral or parenteral feedingo In patients with absolute nutritional deficiencieso Due to inappriopriate planning of nutritional therapy (not a stepwise increase in calory
during nutrition, immediate giving of large calories for malnourished patients)
o Characteristics: Severe electrolyte disturbances Fluid shifts Metabolic disturbances
Phases of Decreased Nutritiono First phase: the amount of structural proteins is maintained.
The energy need is met through: glycogenolysis, gluconeogenesis, ketogenesis,lipolysis
o < 7-10 days: use of stores along with normal serum levelso After 7-10 days: tissue and serum decrease of nutrition and functional disturbance (
organ symptoms),
o
After 10-15 days: pronounced weight losso After 60-70 days: death
NOTE: Read about Postagression Metabolism / Acute phase reaction from lecture notes
7/24/2019 Anaesthesiology and Intensive Care
30/51
Abhishek Narayan, 2007
30/51
14 & 15. The diagnostic steps and treatment of acid-base disturbances
Acidosis:
Increased intake of acids: infusions, conserved blood, intoxication with acids Increased acid production: diabetic or alcoholic ketoacidosis, increased protein metabolism
(endocrine crisis)
Removal of the H+ is disturbed (kidney disease) Loss of base, although acid content is normal: diarrhea, loss of intestinal fluids, certain renaldiseases.
The removal of the CO2 is disturbed: severe lung disorder, respiratory innervation failure
Alkalosis
Increased intake of alkaline materials: overcompensated acidosis by external bicarbonate, increased intake of bicarbonate in case of peptic ulcer.
Kidney is not able to excrete bicarbonate, it increases in the blood. As potassium and H+-excretion are connected, hypokaliemia may also produce alkalosis.
Loosing acids: vomiting
Forced ventilation: the removal of CO2 and the oxygen-intake increases: hysteria, chest wall irritation, irritation of the breathing center, fever, intracranial inflammatory disease, inappropriate mechanical ventilation.
Anion Gap: Anion gap = [Na+ + K] - [Cl- + HCO3-]; normal range: 8 to 16 mmol/l. Concentration of all the unmeasured anions in the plasma. Confirms the presence of a metabolic acidosis Differentiate between causes of a metabolic acidosis: high anion gap versus normal anion
gap metabolic acidosis.
Inorganic metabolic acidosis (eg due HCl infusion), the infused Cl- replaces HCO3and the anion gap remains normal.
Organic acidosis: the lost bicarbonate is replaced by the acid anion which is notnormally measured.AG is increased.
Blood Gas Parameters and Values
pH:: 7,35-7,45. Decreased: acidosis, increased: alkalosis.
pCO2:the pressure of the CO2 in the blood.o Normal value in arterial sample: 34-46 mmHg.o Increases: the lung is not able to remove the CO2,o decreases: too much CO2 is removed.
pO2:The partial pressure of the oxygen in the blood.
o Normal value: > 60 mmHg.o decreased: inappropriate gas exchange in the lung,o increased: hyperventilation.
Standard bicarbonate: reflects the concentration of the bicarbonate. information about themetabolic side of the compensation.
o Normal value: 22-26 mmol/l.o Decrease: lack of base, increase: excess of base.
7/24/2019 Anaesthesiology and Intensive Care
31/51
Abhishek Narayan, 2007
31/51
Actual bicarbonate:Reflects the metabolic side.o Normal value: 25 mmol/l.o Decrease: lack of base, increase: excess of base.
Buffer base (BB):The overall base content of the organism. Reflects the metabolic side.o Normal value: 45-52 mmol/l.
BE (base excess):Reflects the metabolic side.o Positive: base excess or lack of acids,o negative: lack of base or acid excess.o Normal value: -2,5 - +2,5 mmol/l.o Calculation of bicarbonate needed for compensation of a metabolic acidosis: bicarbonate
(ml)= BEx0,3x body weight
Acute Acid Base disturbances
pH pCO2 HCO3-
Acute ventilatory failure (respiratory
acidosis) -
Acute alveolar hyperventilation
(respiratory alkalosis) -
Acute metabolic acidosis -
Acute metabolic alkalosis -
Chronic Acid Base Disturbances
pH pCO2 HCO3-
Chronic ventilatory failure
(compensated respiratory acidosis)-
Chronic alveolar hyperventilation
(compensated respiratory alkalosis)- -
Chronic metabolic acidosis -
Chronic metabolic alkalosis -
Treatment
Metabolic Acidosis:o Correction of the underlying cause.o If needed give bicarbonate (when the pH is less than 7.1-7.2)
Dose (mEq) = 0.3 x Wt (kg) x SBE (mEq/L)o ER Care:raise the systemic pH above 7.1-7.2, a level at which dysrhythmias become less
likely and cardiac contractility and responsiveness to catecholamines will be restored.
Metabolic Alkalosiso underlying cause must be corrected.o Oral or intravenous replacement of extracellular volumeo alkalosis cannot be corrected until potassium is repleted.o In severe cases, unresponsive to other measures, ammonium chloride may be given (1 to
2 g orally every 4 to 6 hours to a maximum of 4 g every 2 hours; or by intravenous
infusion of 100 to 200 mEq dissolved in 500 to 1000 ml of isotonic saline) in addition to
potassium replacement.
7/24/2019 Anaesthesiology and Intensive Care
32/51
Abhishek Narayan, 2007
32/51
Respiratory Acidosiso correct the underlying disordero Rapid correction of the hypercapnia can alkalinize the cerebrospinal fluid, causing
seizures and also inducing a metabolic alkalemia.
o Infusion of sodium bicarbonate rarely is indicated. It may be considered incardiopulmonary arrest at extremes of pH (
7/24/2019 Anaesthesiology and Intensive Care
33/51
Abhishek Narayan, 2007
33/51
7/24/2019 Anaesthesiology and Intensive Care
34/51
Abhishek Narayan, 2007
34/51
16. Sepsis and Multiple Organ Failure
Terms to know:
Sepsis: inflammatory reaction related to infection, provided that 2 of the following are presento Body temp.: 38 C, Pulse rate: >90/min, Breathing frequency 20/min,
PaCO2
7/24/2019 Anaesthesiology and Intensive Care
35/51
Abhishek Narayan, 2007
35/51
Cardiovascular decomposition caused by infection or infection-induced mediatorproduction
Characteristics:o Hypotension lasting for > 1 hour despite adequate volume therapy
(SAP < 90 mmHg, or decrease exceeds > 40 mmHg)
o Distributive shock, low SVR, high CO, Increased capillarypermeability, frequent myocardial dysfunction, severe cellular
dysfunction, apoptosis, MOF
Hematologicalo Bleeding, Thrombotic episodes, DICo Thrombocytopenia, pathological RBC count, PT and aPTT increased, Protein C
decreased, FDP increased, D-dimer increased
Gastrointestinalo GI bleeding or perforation, Ileus, Bowel ischemia, infarct, Acute pancreatitiso Amylase and lipase increased, pH decreased
Neurologicalo Consciousness disturbance, Confusion, Delirium, Septic encephalopathy
o BIS, EEG Endocrine, Immune
Diagnostic: Inflammatory Markers:o Interleukin -1, -6, -8, -10o TNF , CRPo Procalcitonin: most sensitive and earliest
7/24/2019 Anaesthesiology and Intensive Care
36/51
Abhishek Narayan, 2007
36/51
17. Intrahospital transport of the critically ill
Types of transfer:o Hospital to hospital transfero Transport within the hospital.
Pre-transport coordination and communication.
Personnel who accompany the patient. Equipment for monitoring and therapy.
Provide immediate medical and nursing care for resuscitation of patient.
Documentation
Risk to the patient and sometimes to the personnel.
Decision on transport: potential benefits of transport weighted against the potential risk.
A period of transport = period of potential instability.
Does the planned diagnostic procedure alter the treatment of the patient?o Could it not be performed at the ICU?
7/24/2019 Anaesthesiology and Intensive Care
37/51
Abhishek Narayan, 2007
37/51
18. Brain Death
Steps of Diagnosis:
Complete absence of brain activityo Clinical neurological signs
Dolls Eyes, Pupil light reactions, corneal reflex, auditory reactiono
Apnea test Arterial cannul Breathing with FiO2 1,0 -10 min Disconnecting from the respirator, providing oxygen: 6 l /min. Undress the patient, check breathing movements Serial arterial blood gas measurements Brain death: pCO2: 60 Hgmm or above, no spontaneous breathing activity Return to mechanical ventilation, donor management
o Vestibulo-ocular testingo Other investigations:
EEG, EP, TCD, angiography
Irreversibility
o Regular observation of all clinical signs primary brain damage year 3- childhood-adulthood: 12 hours secondary brain damage: 72 hours 5 weeks- 3 years: 24 hours (both primary and secondary) newborns: 72 hours
o OR: proven clinical signs + other tests
7/24/2019 Anaesthesiology and Intensive Care
38/51
Abhishek Narayan, 2007
38/51
19. Donor Conditioning
Live Donoro Kidney, bone marrow, liver, cutis
Cadaver Donoro Kidney, liver, pancreas, hear, lung
Conditions not suitable for donations:
o Patient refused donationo Medical causes
Malignancy, sepsis, infectious disease (HIV, Tbc), metabolic coma, intoxication,muscle relaxation, hypothermia, mechanical ventilation for more than 7 days (?)
Kidney Donation:o Criteria:
age: 4-70 years, maintained circulationo Contraindications:
known kidney disease, kidney trauma, hypotension for more than 1 hour (below60 mmHg), proteinuria of kidney origin, creatinin>300umol/l
o Relative contraindications severe hypertension , severe long-lasting insulin dependent diabetes
o Diagnostic tests: KN, creatinin, urine, Others: abdominal US, chest X-ray., serological assessments
Livero Criteria:
age: 2-60, maintained circulationo Contraindications:
Known liver disease, alcohol, drug-abuse, hepatotoxic drugs, liver damage,abdominal infection, long lasting hypernatremia (Na: higher than 170 mmol/l),
Long lasting respirator therapy, severe obesity
o Diagnostic tests: liver functions: Se Bilirubin, GOT, GPT, gamma GT, AP, prothtrombin, urine
bilirubin, ubg, serum albumin, serology: HIV 1-2, HBsAg, Hepatitis C, CMV,
Other: abdominal US
Heart:o Criteria:
age: below 45, maintained circulationo Contraindications:
known cardiac disease (valvular lesion, CMP, congenital, coronary artery), severehypertension, heart trauma or damage, chatecholamine in high dose (10 ug/kg/min
or more), long-lasting mechanical ventilation( 7 days), Long lasting hypotension
Diagnostic tests:
serology: HIV 1-2, Hepatitis C, CMV, auscultation, 12 lead EKG, BP,pulse rate, CVP, chest X-ray, Others: CK, CK-MB, LDH,
echocardiography, chest X-ray Lungs
o Criteria Age below 65, maintained circulation, ventilation: FiO2 below 40 %, PEEP:
below 5 water cm , normal blood gases
o Exclusion criteria: known pulmonary disease (tbc. asthma), smoking history, severe thoracic trauma,
infection, atelectasis, high arterio-alvelolar oxygen gradient (FiO2= 1, PEEP= 5
water cm, arterial oxygen below 35 mmHg), ventilation with high plateaupressure (30 water cm or more)
7/24/2019 Anaesthesiology and Intensive Care
39/51
Abhishek Narayan, 2007
39/51
Special Problems:o Hemodynamic disturbances
Hypovolemia
Systemic vasodilation (sympathicolysis)
Diabetes insipidus
Hyperglycemia Bleeding (polytrauma)
Inappropriate volumen therapy
Treatment goals:o MAP 65 mmHg or aboveo Cardiac index: 2.1 l/mino PCWP: 12-15 mmHgo CVP:12 mmHgo Diuresis: 100 ml/h or aboveo Arterial O2 (PaO2): 100 Hgmm or above
Myocardial ischaemia
Hypertension (catecholemine-storm): beta-blockers
Bradyarrhythmia: atropin ineffective, catecholamin (dobutamin) Supraventricular and ventricularis tachycardia: beta-blocker or
antiarrythmics
Hypotension: catecholamine, volume therapy, treatment of diabetesinsipidus
Thermoregulation disturbance
Causes:o damage of thermoregulatory center, peripheral vasoparalysis, cold
infusions, low environmental temperature
Goal: normothermia, passive warming, warmed infusions
Endocrine dysfunction
o Metabolic disturbances Hypernatremia
cause: diabetes insipidus, diureticum
Th: isotonic saline, 5% glucose, spironolacton, substitution Hypokalaemia, hypomagnesaemia, hypophosphataemia
cause: volume loss Hypocalcaemia
Cause: acut tubular necrosis, insufficient intake, CPD-conserved bloodproduct
Th: Calcium-chloride
o Mechanical ventilation Goals:
pH=7.4, SpO2 >95%, Tidal volume: 8-10 ml/ kg, FiO2 < 40%
PEEP< 7 wcm, normocapnia,
7/24/2019 Anaesthesiology and Intensive Care
40/51
Abhishek Narayan, 2007
40/51
20. Intravenous Anesthesia
Phases of Anesthesia:
Premedication (Topic 23)
Anesthesia induction
Anesthesia maintenance
Recovery phase Postoperative observationDrugs:
Rapidly acting (primarily induction) agentso Barbiturates: methohexital and thiobarbiturates
Thiopental and methohexital: high lipid solubility, promotes entry into brain, andfaster surgical anesthesia
Used for short procedures Note: respiratory and circulatory depressants, also decrease cranial blood flow
o Imidazole compounds: etomidate Rapid induction with minimal change in cardiac function or respiratory rate, but is
not analgesic
o Sterically hindered alkyl phenols: propofol Raster and better recovery then barbiturates Antiemetic actions, may cause hypotension via decrease in peripheral resistance
Slower acting (basal narcotic) agents:o Ketamine
Dissociative anesthesia: pt awake but has marked catatonia, analgesia, andamnesia
May increase ICPo Benzodiazepines: diazepam, flunitrazepam, midazolam
Used with inhaled, and with IV opioids Slower but longer acting then the barbiturates
Can use Flumazenil to speed recovery
o Large-dose opioids: fentanyl, alfentanil sufentanil, remifentanil Very helpful in high risk patients who may not survive a full general May cause chest wall rigidity
o Neuroleptanesthesia combination: opioid + neuroleptic State of analgesia and amnesia produced when fentanyl is used with droperidol
and nitrous oxide.
Advantages using IVA for maintenance:o Minimal cardiovascular depressiono Rapid recovery profile (with propofol only)o Higher oxygen concentration in some circumstances, such as:
One-lung anesthesia
Severe trauma Some procedures (laryngoscopy, bronchoscopy, electroshock)
o Situations where avoidance of N2O is necessary
7/24/2019 Anaesthesiology and Intensive Care
41/51
Abhishek Narayan, 2007
41/51
21. Inhalational Anesthesia
Used mainly for maintaining anesthetic state.
Gas at room temperature: nitrous oxide, xenon
Fluid at room temperature: halothane, enflurane, isoflurane, methoxyflurane, sevoflurane,desflurane vaporizer is needed
o Gases partial pressure in the inhaled air or in the blood or other tissue is a measure oftheir concentration (Henry Laws)
Site of Actiono GABA-associated chloride channel: stimulationo Voltage-dependent Ca-channels (T, L and N type): isofluraneo NMDA receptor: N2O, xenono Muscarinic effect in CNS (memory and consciousness): desflurane (M1), isoflurane (M1
and M3),sevoflurane (M1), halothane (M1 and M3)
o Nicotinergic: allo Voltage-dependent Na-channel inhibition: halothane, enflurane, isoflurane, desflurane,
sevoflurane
o
Solubilityo More rapid the equilibration in the blood, the more quickly the drug passes into the brain
produce anesthetic effects
o Drugs with LOW blood:gas partition coefficient (N2O), equilibrate faster Oswald Ratio
> 1 - better solubility in blood
< 1 less blood solubilityo Greater amount is necessary from the lung to reach the needed
concentration, but if it is in the blood soluble form, the diffusion to
the tissues is easier
o Minimum Alveolar Concentration (MAC): the concentration that eliminates the response
in 50% of patients exposed to a standard painful stimulus Modified MACs
MAC EI50 MACEI95: in 50, or 95% of the patients laryngoscopy andintubation possible
MAC BAR50and MAC BAR95: adrenergic reactions to incision areblocked in 50, or 95% of the patients
Increases MAC: age (children), hyperthermia, hyperthyreosis, sympathomimetics Decreases: hypothermia, gravidity, hypoxia, hypotonia, anemia, other drugs
Distributiono 75% vessel rich group (brain and heart), 8-10% fat, 15% muscle group, rest: vessel poor
group
o Fat: takes relative large amount of anesthetics will be important in the recovery
period. Factors affecting Anesthetics
o Inspired gas partial pressure, ventilation rate, pulmonary blood flow, AV concentrationgradient (Oswald ratio), Duration of anesthesia
o Mostly affect the high solubility group of gases.
Anesthesia Systemso Open
Inhalational anesthetics enters the patient as a transported gas by the room air, ieSchimmelbush mask
o Semi-open
7/24/2019 Anaesthesiology and Intensive Care
42/51
Abhishek Narayan, 2007
42/51
Narcotics is carried to the patient by fresh gaso Semi-closed
A certain amount of exhaled gases will be re-breathed, another amount will beremoved
o Closed systems Exhaled gas mixture is given back in its total amount to the system, after CO2-
absorption
7/24/2019 Anaesthesiology and Intensive Care
43/51
Abhishek Narayan, 2007
43/51
22. Anesthesiology Risks
In 9% of all patients, at least one type of complication happens.
Factors increasing the risk:o Duration of surgery,Age, Urgent surgery
Most Frequent complications:
o Cardiac arrhythmias Bradycardia:
Cause:o Drug side effect, Surgical manipulation, Hypotermia, Metabolic
disturbances
Treatment: atropin, catecholamins Tachycardia
Cause:o improper anesthesia or analgesia, hypoxia, hypercapnia,
hypovolaemia
Treatment: treat the cause! Most Frequent Causes:
Cardio-respiratory: hypoxia, hypotension, hypo-hypercapnia, myocardialischemia
Metabolic: catecholamine-effect, hypo-and hyperkalemia, malignanthyperthermia
Surgical: Increase of vagal tone, direct cardiac stimulation,
Drugs: vagolythic, sympathomimetics, halothane, enflurane,o Hypotension
MAP= below 60 mmHg If decrease of systolic BP reaches 25% (especially in previous HT) In coronary artery diseases diastolic BP is important (coronary perfusion) Causes:
Cardiorespiratory:o Hypovolemia: improper preoperative fluid load, gastrointestinal
fluid loss, bleeding
o Obstruction: embolia, aorto-caval compression, pericardialtamponade
o Rise in intrathoracal pressure: IPPV/PEEP, PTX
Myocardialo Decreased contractility: drug effect, acidosis, ischemia, AMI,
Arrhythmia, Pericardial tamponade
Drugs:o Absolute or relative overdose, central regional blocko Allergic reaction (drug, colloid, blood)o direct histamine release
o Hypovolemia: Preoperative:
bleeding: trauma, gynecological, gastrointestinal, rupture of large vessels
Gastrointestinal: vomiting, fistulas, diarrhea
Other: diuretic, fever, burn Intraoperative:
bleeding, Insensible perspiration, Drainage of bowel, ascites, Loose to the3rd space.
7/24/2019 Anaesthesiology and Intensive Care
44/51
Abhishek Narayan, 2007
44/51
o Hypertension Previous hypertension
Not known, Pregnancy-induced, Stopping antihypertensive treatment Increased sympathetic tone
Improper analgesia, Improper depth of anesthesia, Airway manipulation,Hypercapnia
Drug-overdose:
Epinephrin, ephedrin, Ketamin Other: hypervolemia, aortic clamp, pheochromocytoma, malignant hyperthermia
o Drug side effects Hypersensitivity, idosynchrasy, drug interations
o Embolisation Gas Thrombi
o Respiratory Complication Hypoxemia,
Low Fi02 of the inspired gas
Hypoventilation
Ventilation-Perfusion Insufficiency Hypercapnia ( Elimination failure or Increased production), Hypocapnia Airway obstruction (Equipment failure or Patient Related), Laryngospasm
Can be caused by: insufficient depth of anesthesia, secretum or bloodwithin the pharynx, irritative inhalational agent, administration of
barbiturates
Bronchospasm
Can be caused by: Admin of Beta Blockers, Drugs inducing histaminerelease
PTX, Intubation complications Aspiration of the gastric contents
o Improper mechanical ventilationo Temperature Alterations
Hypothermia
Decreased heat production:o Anesthetics decreases metabolic rate, and shivering
Decreased heat loss:o Vasodilatation, air conditioning,o Exporative heat loss: mechanical ventilation, sweating, open
cavities (especially abdominal and thoracal)
Can lead to:o CO decreases, decrease in tissue oxygenation, in severe cases:
metabolic acidosis, oliguria, Hyperthermia
Causes: Sepsis, Drug effects, Excessive catecholamine-release
Can lead to: CO increases Oxigen demand increases, minute ventilation increases, acidosis Treatment: cooling (surface and intravenous fluid)
o Physical injuries Damage to nerves, teeth, corneal drying
7/24/2019 Anaesthesiology and Intensive Care
45/51
7/24/2019 Anaesthesiology and Intensive Care
46/51
Abhishek Narayan, 2007
46/51
24. Regional Anesthesia
Definition
Regional anesthesia is the blockade of nerves that causes anesthesia of regional distributionwhile consciousness is preserved.
Full aseptic and antiseptic precautions must be taken.
Advantages:o The patient remains conscious, the recovery is uncomplicated, extension of the blockade
provides effective analgesia, reduces metabolic and endocrine changes, blood loss is
reduced, less expensive, faster discharge
Disadvantageso The patient remains conscious, some blocks need up to 30 min to be fully effective,
analgesia is not always fully effective, generalized toxicity may occur, widespread
sympathetic blockade causes hypotension, not suitable for all operations
Immediate complications:o Sensitivity, hypotension, respiratory paralysis pain on injection, motor paralysis, urinary
renention
Late complications:o Nerve trauma, anterior spinal artery syndrome, adhesive arachnoiditis (spinal, epidural),
pneumothorax (intercostal, interpleural, supraclav. brach. plexus), headache (spinal)
Types:o Central (spinal, epidural, caudal)o Peripheral (any peripheral nerve)
Spinal Anesthesiao Anesthetic agent is injected into the cerebrospinal fluid that causes widespread blockade
of the spinal nerves. Can be single or continuous (catheter)
o Patient position: sitting or lateral with spine fully flexedo Puncture site : L2-3, L3-4, L4-5 interspace
Penetrate: Supraspinous and interspinous lig, lig flavum, dura mater, arachnoid
matter Spinal cord ends at L2, dural sac at S2o Drugs used: bupivacaine, articain, fentanylo Contraindications:
Absolute
Patient refusal, infection at puncture site, uncorrected hypovolemia Relative:
Bacteremia, pre-existing neurologic disorders, heparin therapyo Effects:
Motor and sensory blockade, SNS blockade, bradycardia, venodilatation, decreasein bp,
Epidural Anesthesia
o Blockade of nerves of the epidural space, that lie within the spinal canal but outside thedura mater. Touhy needle is used
o Contraindications are the same as aboveo Single or continuous EDA
First test dose, then main dose is injectedo Anesthesia( concentrated solution in large dose) or pain control (dilute solution in small
dose)
o Drugs: local anesthetics, morphine derivates, alpha-agonists
7/24/2019 Anaesthesiology and Intensive Care
47/51
Abhishek Narayan, 2007
47/51
o Effects: Motor and sensory block depends on dose and concentration. Hemodynamic effects: SNS blockade is milder and more gradual in onset than
with spinal.
Caudal Anesthesiao Injection of local anesthetic through the sacral hiatus into the sacral (epidural) canalo Large dose is needed because of the large canal and free leakage through the foraminao Anesthesia or analgesiao Single or catheter technique
Biers Blocko Limb is isolated from the circulationo Local anesthesia is injected.o The drug reaches the capillaries by retrograde flow, gets
into the extravasc. space and reaches nerve endings
causing paralysis below the cuff
Local Anesthesia drugso Potency is related to lipid solubilityo Duration of action is related to protein binding and blood
supplyo Esters
Long Acting tetracaine, amethocaine Short Acting procaine Surface action benzocaine, cocaine
o Amides Long action bupivacaine, ropivacaine Medium action lidocaine (max 3mg/kg), prilocaine
o Can be combined with Bicarbonate increase pH (increases unionized LA) Adrenaline decrease vascular reabsorption, increasing duration Opiopds synergism with epidural LA, morphine 2-5mg
Clonidine prolongs duration of sensory and motor block
Refer to OXFORD HANDBOOK OF ANAESTHESIA for more info on regional blocks
7/24/2019 Anaesthesiology and Intensive Care
48/51
Abhishek Narayan, 2007
48/51
25. Guidelines of acute and chronic Pain relief
Pain:
unpleasant sensory and emotional experience associated with actual or potential tissue damage,always subjective
Factors influencing perception
o Physical, Depression, Anger, Anxiety Pain assessment:
o Believe the patients complaint, assess the severity of the pain.o Assess the psychological state of the patient.o Take a detailed history of the pain.o Perform a careful physical examination.o Order, and personally review, any necessary diagnostic investigations.o Consider alternative methods of pain control during the initial evaluation.
Describing Paino Verbal Description Scaleo Numerical Rating Scaleo Visual Analogue Scaleo Ocuher scale for kids
Acute Pain:o Usually self limitingo Usually a progressive improvement over a short periodo Unrelieved pain is associated with:
Outpouring catecholamines, risk of tachycardia, dysrhythmias and decreasedmyocardial oxygenation.
Reduced functional residual capacity Reduced sputum clearance and risk of atelectasis Peripheral vasoconstriction Metabolic acidosis
o Pharmacological Paracetamol:
Inhibit prostaglandin syn, both analgesic and antipyretic
4g/d NSAIDS:
Analgesic, anti-inflam, anti-pyretic, anti-platelet
Diclofenac(50mg), Ibuprofen (400mg),Ketorolac (10mg) Inhalation analgesia:
Entonox (50% nitrous oxide, 50% oxygen)
Isoflurane (0.2-0.75% in Entonox) Opioids:
Morphine, papaveretum, Pethidine, Methadone
Fentanly: highly lipid soluble, short duration, good for trans dermal admin Codeine: prodrug for morphine
Tramadol: synthetic centrally acting opioid like drug,o Inhibit the serotonin and noradrenaline update at never terminals
Infusions for 2-3 days
only, tolerance occurs quickly
Side effects: respiratory depression, sedation, euphoria, nausea andvomiting,
Opioid Antagonist: Naloxone Simple Analgesics
7/24/2019 Anaesthesiology and Intensive Care
49/51
Abhishek Narayan, 2007
49/51
Ketorolac aka Toradol, IM/IV (0.5mg/kg up to 30mg qds) for post op painfor 5 days
NSAID
Not for use preioperativeo Interruption of Pain Afferents
Direct injection of local analgesic drugs close to peripheral nerves, major nervetrunks or nerve roots: blocking conduction of afferent impulses.
Using Local Anagesic:
Spinal subarachnoid blocko Use long lasting drug like bupivacain for long lasting effects, or
opioid drug before blocks wears
Epidural analgesia, caudal epidural analgesia
Intercostal block, nerve blocks Other Methods:
Inhalational methodso Entonox, note nitrous oxide can cause pancytopenia
Transcutan Electrical Nerve Stimulation (TENS)o TENS acts by increasing c.s.f. levels of B endorphins, together
with activation of the pain gate by counter irritation. Cryotherapy
Physical methods of pain relief
Chronic Pain:o Intractable pain is
severe, incapacitating, resistant to all forms of treatment by non-opioid drugs orphysical therapies.
o Pain is described as chronic when it persists for more than 6 monthso Pain threshold is lowered by continuous paino There are five groups of patients with chronic pain associated with cancer:
Due to cancer, due to treatment, dying, Are / have been drug dependent, pain notdue to cancer but have cancer
o Goal of Therapy: To relieve pain, to manage associated depression or anxiety, to prevent / relieve
side effects of drugs (especially nausea, constipation), to assist sleep.
o Drugs: The simple analgesics
Paracetamol (max 4g.day) and aspirin(max 4g.day) The weak analgesics
Codeine phosphate, Oxycodone The potent opioid drugs
Morphine, Methadone, Dextromoramide, Pethidine, Diamorphine
Note: Morphine is contraindicated in:
o tension headache and migraines, arthritis, muscle spasmo burning pain caused by nerve damage, neuralgic pain
Adjuvant analgesic drugs
anticonvulsant drugs for relief of neuralgic pain
antispasmodic drugs for relief of muscle spasm
in low dose the tricyclic antidepressants will help sleep and they mayhelpful in reducing the burning pain associated with nerve damage.
Corticosteroidso Relief of headce of raised intracranial pressure
Inhalational methods of analgesia
7/24/2019 Anaesthesiology and Intensive Care
50/51
Abhishek Narayan, 2007
50/51
26. Cardiopulmonary Resuscitation (ALS)
http://www.resus.org.uk/pages/als.pdf
o Arrhythmias associated with cardiac arrest are divided into two groups: shockable rhythms(VF/VT) and non-shockable rhythms (asystole and PEA).
o The principle difference in management is the need for attempted defibrillation in patients with
VF/VT.o Subsequent actions, including chest compression, airway management and ventilation, venous
access, administration of adrenaline, and the identification and correction of reversible factors,are common to both groups.
o The ALS treatment algorithm provides a standardised approach to themanagement of adult patients in cardiac arrest.
Shockable rhythms (VF/VT)o Sequence of actions
o Attempt defibrillation (one shock - 150-200 J biphasic or 360 J monophasic).o Immediately resume chest compressions (30:2) without reassessing the rhythm or
feeling for a pulse.o Continue CPR for 2 min, then pause briefly to check the monitor:
If VF/VT persists
Give a further (2nd) shock (150-360 J biphasic or 360 J monophasic). Resume CPR immediately and continue for 2 min.
Pause briefly to check the monitor.
if VF/VT persists give adrenaline 1 mg IV followed immediately by a (3rd)shock (150-360 J biphasic or 360 J monophasic).
Resume CPR immediately and continue for 2 min.
Pause briefly to check the monitor.
If VF/VT persists give amiodarone 300 mg IV followed immediately by a(4th) shock (150-360 J biphasic or 360 J monophasic).
o Lidocaine 1 mg kg-1 may be used as an alternative if amiodarone
is not available, but do not give lidocaine if amiodarone has beengiven already.
Resume CPR immediately and continue for 2 min.
Give adrenaline 1 mg IV immediately before alternate shocks (i.e.approximately every 3-5 min).
Give a further shock after each 2 min period of CPR and after confirmingthat VF/VT persists.
If organised electrical activity is seen during this brief pause in compressions,check for a pulse.
If a pulse is present, start post-resuscitation care.
If no pulse is present, continue CPR and switch to the nonshockablealgorithm.
If asystole is seen, continue CPR and switch to the nonshockable algorithm.
Non-shockable rhythms (PEA and asystole)o Pulseless electrical activity (PEA) is defined as cardiac electrical activity in the absence of any
palpable pulse.o These patients often have some mechanical myocardial contractions but they are too weak to
produce a detectable pulse or blood pressure.o PEA may be caused by reversible conditions that can be treated if they are identified and
corrected (see below).
7/24/2019 Anaesthesiology and Intensive Care
51/51
Abhishek Narayan, 2007
o Survival following cardiac arrest with asystole or PEA is unlikely unless a reversible cause canbe found and treated effectively.
o Sequence of actions for PEAo Start CPR 30:2.o Give adrenaline 1 mg IV as soon as intravascular access is achieved.o Continue CPR 30:2 until the airway is secured, then continue chest compressions
without pausing during ventilation.o Recheck the rhythm after 2 min.o If there is no change in the ECG appearance:
Continue CPR. Recheck the rhythm after 2 min and proceed accordingly. Give further adrenaline 1 mg IV every 3-5 min (alternate loops).
o If the ECG changes and organised electrical activity is seen, check for a pulse. If a pulse is present, start post-resuscitation care. If no pulse is present:
Continue CPR.
Recheck the rhythm after 2 min and proceed accordingly.
Give further adrenaline 1 mg IV every 3-5 min (alternate loops).
o Sequence of actions for asystole and slow PEA (rate < 60 min-1)o Start CPR 30:2.o Without stopping CPR, check that the leads are attached correctly.o Give adrenaline 1 mg IV as soon as intravascular access is achieved.o Give atropine 3 mg IV (once only).o Continue CPR 30:2 until the airway is secured, then continue chest compression without
pausing during ventilation.o Recheck the rhythm after 2 min and proceed accordingly.o If VF/VT recurs, change to the shockable rhythm algorithm.o Give adrenaline 1 mg IV every 3-5 min (alternate loops).
Top Related